... (Reuters) - Price increases spread among seven of
the 10 drugs in 2021 behind... Medical Officer David
Rind told Reuters.
In 2020,…
The pharmaceutical company prepared well as Humira approaches its patent cliff next year....…
-- Fifteen abstracts underscore AbbVies commitment to people living with migraine -- AbbVie to present late-breaking data from the Chronic…
DUBLIN, Dec. 5, 2022 /PRNewswire/ -- The "Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target,…
NEW YORK, Dec. 5, 2022 /PRNewswire/ -- The HIV treatment drugs market size in Africa is forecast to grow by…
The pharma giants story wont be over with anticipated sales declines for its top-selling drug....…
Abbvie has racked up nearly $200 billion in Humira sales, but it has lost patent protection in Europe and faces…
DUBLIN, Dec. 2, 2022 /PRNewswire/ -- The "Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027" report has…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
WASHINGTON (dpa-AFX) - AbbVie Inc. (ABBV) Thursday announced provincial reimbursement for RINVOQ for the treatment of rheumatoid arthritis and psoriatic…
DUBLIN, Nov. 29, 2022 /PRNewswire/ -- The "Pharmaceutical Industry in the United States 2022" report has been added to ResearchAndMarkets.coms…
NEW YORK, Nov. 28, 2022 /PRNewswire/ -- The multiple myeloma drugs market size is estimated to grow by USD 6,419.94…
These pharmaceutical companies are profitable and offer above-average dividends....…
This is a stock that rewards long-term investors through continual dividend increases....…
DUBLIN, Nov. 23, 2022 /PRNewswire/ -- The "Clinical Trials - The Importance of Diversity in Clinical Trials" report has been…
NORTH CHICAGO, Ill., Nov. 23, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 5th Annual Evercore ISI Virtual…
Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year....…
- Nearly 65 abstracts, including 15 oral presentations on 7 investigational and approved medicines across 8 cancer types, to be…
read more...…
Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), PepsiCo, Inc. (PEP) and The…
...By Brendan Pierson
(Reuters) - Teva Pharmaceutical Industries Ltd......…
The pharmaceutical companys golden goose is about to stop laying golden eggs, but that wont be a permanent problem....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
COPENHAGEN (dpa-AFX) - AbbVie (ABBV) announced the FDA has accepted for priority review the Biologics License Application for epcoritamab, an…
AbbVie, Genmab Get FDA Priority Review of Epcoritamab in Large B-Cell Lymphoma...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Latest Ratings for ABBV
DateFirmActionFromTo Feb 2022UBSDowngradesBuyNeutral Feb 2022MizuhoMaintainsBuy Feb 2022BarclaysMaintainsEqual-Weight
View More Analyst Ratings…
ALEXANDRIA, Va., Nov. 17, 2022 /PRNewswire/ -- AMCP Foundation congratulates the student pharmacists who recently completed immersive managed care centered…
A RECORD-BREAKING NUMBER OF CONSUMERS PARTICIPATED, WITH BOGO GIFT CARDS SELLING OUT IN JUST A FEW HOURS11 IRVINE, Calif., Nov.…
Thirty-six abstracts underscore AbbVies commitment to advancing research to help more people living with rheumatic diseases Additional analysis of long-term…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced results from its exploratory NOVA phase 2 dose-ranging study evaluating the efficacy and safety…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The drugmaker has something to offer to all kinds of investors....…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Both these companies pay a dividend, but the similarities stop there....…
Continued progress on 5x25 strategy to advance five AAV Therapeutics from our internal pipeline and licensed programs into pivotal-stage or…
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…